Article 1
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2018/1262 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-methylcyclopropene, beta-cyfluthrin, chlorothalonil, chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, dimethenamid-p, diuron, fludioxonil, flufenacet, flurtamone, fosthiazate, indoxacarb, MCPA, MCPB, prosulfocarb, thiophanate-methyl and tribenuron (Text with EEA relevance.)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .
ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2019’; (2) in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2019’; (3) in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by ‘31 October 2019’; (4) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2019’; (5) in the sixth column, expiration of approval, of row 67, Dimethenamid-p, the date is replaced by ‘31 October 2019’; (6) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2019’; (7) in the sixth column, expiration of approval, of row 101, Chlorothalonil, the date is replaced by ‘31 October 2019’; (8) in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2019’; (9) in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2019’; (10) in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2019’; (11) in the sixth column, expiration of approval, of row 105, Thiophanate-methyl, the date is replaced by ‘31 October 2019’; (12) in the sixth column, expiration of approval, of row 106, Tribenuron, the date is replaced by ‘31 October 2019’; (13) in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2019’; (14) in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2019’; (15) in the sixth column, expiration of approval, of row 117, 1-methylcyclopropene, the date is replaced by ‘31 October 2019’; (16) in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2019’; (17) in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2019’; (18) in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2019’; (19) in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2019’; (20) in the sixth column, expiration of approval, of row 192, Diuron, the date is replaced by ‘30 September 2019’.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.